No Data
No Data
No Data
Qingdao Vland Biotech INC.'s (SHSE:603739) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Most readers would already be aware that Qingdao Vland Biotech's (SHSE:603739) stock increased significantly by 45% over the past three months. But the company's key financial indicators appear to b
Azure Biotech (603739.SH) will distribute the 2023 cash dividend of 0.1 yuan per share on May 30
Azure Biotech (603739.SH) announced that the company will release the 2023 fiscal year on May 30, 2024...
The stock price has doubled since April 25th! Azure Creatures (603739.SH): There may be irrational hype
Blue Biotech (603739.SH) announced that the company's shares will be traded for 10 consecutive trading days (April 25, 2024...
Cumulative stock price increase of more than 100% Blue Bio (603739.SH): There are no conditions for industrialization in the field of synthetic biology
On May 9, Ge Longhui (603739.SH) announced serious abnormal fluctuations in stock trading. The cumulative deviation value of the company's stock closing price increase exceeded 100% within 10 consecutive trading days (April 25, 2024 to May 9, 2024). According to the relevant provisions of the “Shanghai Stock Exchange Trading Rules”, this is a serious abnormal fluctuation in stock trading. Recently, the company noticed that the Internet and some media published reports on “synthetic biology.” The company has set up only 1 synthetic biotechnology innovation laboratory in the field of synthetic biology, which is mainly used to develop feed functionality
Blue Biology (603739.SH): The company has set up only 1 synthetic biotechnology innovation laboratory in the field of synthetic biology
Blue Biotech (603739.SH) announced that the company's stock has been rising and stopping for 5 consecutive trading days, and the stock price has fluctuated recently...
Synthetic organisms are now differentiated! Big bulls have advanced to the 5th straight board, and policy expectations haven't been met yet?
There will be major policies in the future
No Data